KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 134 filers reported holding KARYOPHARM THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 5.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,300 | -25.1% | 6,194 | 0.0% | 0.00% | – |
| Q2 2023 | $11,087 | -54.0% | 6,194 | 0.0% | 0.00% | -100.0% |
| Q1 2023 | $24,095 | +19.7% | 6,194 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $20,131 | -39.0% | 6,194 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $33,000 | +22.2% | 6,194 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $27,000 | -41.3% | 6,194 | 0.0% | 0.00% | -50.0% |
| Q1 2022 | $46,000 | +15.0% | 6,194 | 0.0% | 0.00% | +100.0% |
| Q4 2021 | $40,000 | +11.1% | 6,194 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $36,000 | -43.8% | 6,194 | 0.0% | 0.00% | -50.0% |
| Q2 2021 | $64,000 | -1.5% | 6,194 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $65,000 | -32.3% | 6,194 | 0.0% | 0.00% | -50.0% |
| Q4 2020 | $96,000 | +6.7% | 6,194 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $90,000 | -23.1% | 6,194 | 0.0% | 0.00% | -33.3% |
| Q2 2020 | $117,000 | +13.6% | 6,194 | +16.0% | 0.01% | 0.0% |
| Q1 2020 | $103,000 | +9.6% | 5,338 | +9.3% | 0.01% | +50.0% |
| Q4 2019 | $94,000 | +100.0% | 4,886 | 0.0% | 0.00% | +100.0% |
| Q3 2019 | $47,000 | +95.8% | 4,886 | +21.6% | 0.00% | +100.0% |
| Q2 2019 | $24,000 | +4.3% | 4,019 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $23,000 | -39.5% | 4,019 | 0.0% | 0.00% | -50.0% |
| Q4 2018 | $38,000 | -44.1% | 4,019 | 0.0% | 0.00% | -33.3% |
| Q3 2018 | $68,000 | 0.0% | 4,019 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $68,000 | +70.0% | 4,019 | +35.5% | 0.00% | +50.0% |
| Q1 2018 | $40,000 | +42.9% | 2,967 | 0.0% | 0.00% | +100.0% |
| Q4 2017 | $28,000 | -6.7% | 2,967 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $30,000 | +11.1% | 2,967 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $27,000 | +17.4% | 2,967 | +66.5% | 0.00% | 0.0% |
| Q1 2017 | $23,000 | – | 1,782 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Delphi Management Partners VIII, L.L.C. | 2,263,006 | $13,170,000 | 9.51% |
| Palo Alto Investors LP | 5,383,052 | $31,329,000 | 1.89% |
| Birchview Capital, LP | 246,000 | $1,432,000 | 0.97% |
| Rubric Capital Management LP | 3,375,758 | $19,647,000 | 0.55% |
| Lombard Odier Asset Management (Switzerland) SA | 1,517,804 | $8,834,000 | 0.55% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,401,861 | $8,159,000 | 0.30% |
| AlphaCentric Advisors LLC | 136,000 | $792,000 | 0.20% |
| Bridgefront Capital, LLC | 20,946 | $122,000 | 0.13% |
| Hennion & Walsh Asset Management, Inc. | 407,474 | $2,371,000 | 0.12% |
| Virtus ETF Advisers LLC | 44,364 | $258,000 | 0.11% |